Over the last decade, CKD-related mineral and bone disorder (CKD-MBD) involving fibroblast growth factor 23 (FGF23), and calcium and phosphate metabolism, has attracted attention as a new risk factor for progression of atherosclerosis and CKD [4]. This evidence concerns the gene FGF23 and Marchiafava-Bignami disease.